Clinical Trials Directory

Trials / Completed

CompletedNCT03752502

Effects of Cerebral and Peripheral Electrical Stimulation on Conditioned Pain Modulation in Healthy Subjects.

Status
Completed
Phase
Phase 2 / Phase 3
Study type
Interventional
Enrollment
50 (actual)
Sponsor
Universidade Federal do Piauí · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

The Neuromatrix pain model and new findings on pain chronification process point to a greater efficacy of treatments that address central and peripheral rather than only peripheral structures. Both cerebral and peripheral electrical stimulations can modulate brain areas involved in pain processing. However, their effects on pain modulation systems and clinical outcomes are lacking. This study aims to investigate the efficacy of transcranial direct current stimulation (tDCS) and peripheral electrical stimulation (PES) alone as well tDCS combined with PES on pressure pain threshold and conditioned pain modulation in healthy subjects.

Conditions

Interventions

TypeNameDescription
PROCEDURETranscranial direct current stimulation (tDCS)Transcranial direct current stimulation (tDCS) is a noninvasive brain stimulation (NIBS) technique that has been investigated for the management of various chronic pain conditions. However, as a monotherapy for pain relief, this therapy still has controversial results.
PROCEDUREPeripheral electrical stimulation (PES)Peripheral electrical stimulation (PES) activates a complex neural network involving a series of neurotransmitters and receptors capable of promoting segmental and extrasegmental analgesia.
PROCEDURESham tDCSTranscranial direct current stimulation (tDCS) is a noninvasive brain stimulation (NIBS) technique that has been investigated for the management of various chronic pain conditions. However, as a monotherapy for pain relief, this therapy still has controversial results.

Timeline

Start date
2018-12-01
Primary completion
2019-11-30
Completion
2021-11-27
First posted
2018-11-26
Last updated
2023-11-28

Locations

1 site across 1 country: Brazil

Source: ClinicalTrials.gov record NCT03752502. Inclusion in this directory is not an endorsement.